Show simple item record

dc.contributor.authorKunutsor, Setor K.
dc.contributor.authorLaukkanen, Jari
dc.date.accessioned2019-04-16T08:37:40Z
dc.date.available2019-04-16T08:37:40Z
dc.date.issued2019
dc.identifier.citationKunutsor, S. K., & Laukkanen, J. (2019). Should inflammatory pathways be targeted for the prevention and treatment of hypertension?. <i>Heart</i>, <i>105</i>(9), 665-667. <a href="https://doi.org/10.1136/heartjnl-2018-314625" target="_blank">https://doi.org/10.1136/heartjnl-2018-314625</a>
dc.identifier.otherCONVID_28911671
dc.identifier.otherTUTKAID_80600
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/63506
dc.description.abstractHypertension is the most common modifiable risk factor for cardiovascular disease (CVD)1 and is a leading cause of death globally.2 Hypertension and CVD share common antecedent risk factors which include physical inactivity, obesity and excess alcohol intake.3 Though these established risk factors explain a large proportion of hypertension risk, its pathogenesis is still not fully established as it appears that other additional lifestyle and genetic factors may be involved. There is therefore a need to identify and evaluate putative risk factors that may increase our knowledge of hypertension development, may have causal or predictive relevance, and which will help develop preventive and management strategies.fi
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherBMJ
dc.relation.ispartofseriesHeart
dc.rightsIn Copyright
dc.subject.otherkohonnut verenpainefi
dc.subject.othertulehdusfi
dc.subject.otherhypertensionfi
dc.subject.otherinflammationfi
dc.titleShould inflammatory pathways be targeted for the prevention and treatment of hypertension?
dc.typearticle
dc.identifier.urnURN:NBN:fi:jyu-201904112156
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalItem
dc.date.updated2019-04-11T12:15:24Z
dc.description.reviewstatusnonPeerReviewed
dc.format.pagerange665-667
dc.relation.issn1355-6037
dc.relation.numberinseries9
dc.relation.volume105
dc.type.versionacceptedVersion
dc.rights.copyright© Author(s) (or their employer(s)) 2019.
dc.rights.accesslevelopenAccessfi
dc.subject.ysokohonnut verenpaine
dc.subject.ysotulehdus
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p21452
jyx.subject.urihttp://www.yso.fi/onto/yso/p1049
dc.rights.urlhttp://rightsstatements.org/page/InC/1.0/?language=en
dc.relation.doi10.1136/heartjnl-2018-314625


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

In Copyright
Except where otherwise noted, this item's license is described as In Copyright